- Dana-Farber Cancer Institute has named Michael Reney its Chief Financial Officer (CFO), where he will be responsible for all financial operations including accounts payable, financial planning and reporting, payroll, capital asset management, tax and general and patient accounting.
- Tari King, MD, has been named Chief of Breast Surgery at Dana-Farber/Brigham and Women's Cancer Center where she will oversee breast surgery and continue to build DF/BWCC's integrated clinical model for treating breast cancer.
- In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute report.
- Regular consumption of caffeinated coffee may help prevent the return of colon cancer
after treatment and improve the chances of a cure, according to a new, large
study from researchers at Dana-Farber Cancer Institute.
- The National Committee for Quality Assurance (NCQA) has recognized four Dana-Farber Community Cancer Care sites in Massachusetts for quality of their patient care services.
- Dana-Farber Cancer Institute scientist Bruce Spiegelman, PhD, who discovered a hormone linked to some of the positive benefits of exercise, reports he has confirmed the hormone — named irisin — is produced in humans and increases during exercise.
Tags: Exercise, Hormones
- Men with metastatic, hormone-sensitive prostate cancer gained more than a year of survival when they received both hormone-blocking medications and chemotherapy right after diagnosis, rather than delaying the chemo until the cancer worsened, according to a study led by Dana-Farber’s Christopher Sweeney published in the New England Journal of Medicine.
Tags: chemotherapy, ProstateCancer
- The Dana-Farber community is saddened by the death of Carolyn Mary Kaelin, MD, MPH, FACS, of Boston, MA, who died on July 28, surrounded by loved ones. A gifted and compassionate breast cancer surgeon, Dr. Kaelin was a surgical oncologist in the Women's Cancers Program at Dana-Farber and director of the Breast Clinic at Brigham and Women's Hospital.
- Study led by Dr. Alexi Wright finds intraperitoneal chemotherapy substantially improves survival of ovarian cancer patients, but that many women who could benefit are not receiving the treatment.
Tags: chemotherapy, OvarianCancer
- Dana-Farber/Brigham and Women's Cancer Center has been named the best for cancer care in New England for the 15th straight year and fourth overall in the country by U.S. News & World Report.
Showing 11-20 of 628 items